Annexin Pharmaceuticals
Annexin Pharmaceuticals: Our Q1 Comment (Redeye)
2021-05-06 12:06
Redeye maintains our positive view of Annexin Pharmaceuticals and Base case of SEK 4 following the company’s report for the first quarter. We give a brief comment on the financials and the key events for the period.
info@redeye.se (Redeye.se)
Redeye AB - Redeye.se